Increasing Share of Indian Generics in the Global Pharmaceutical Market
Over the last two decades, India has gradually evolved into an influential player in the global pharmaceutical market. The country’s pharmaceutical industry is estimated as the third-largest in the world in terms of volume and at USD X billion it was ranked 13th in terms of value in 2012. The Indian pharma sector contributes around X percent of the total global production, including Xpercent of the total volume of global generics. India also manufactures around X percent of the total requirement of anti-HIV drugs.
India is a global market leader in the export of generic drugs. Low production costs give the country an edge over other generics-producing nations, such as China and Israel. India manufactures around X generic brands across X key therapeutic areas. This segment is dominated by anti-infectives, which account for more than X percent of the market share. The government targets around USD X billion in pharmaceuticals export by 2015.